...
首页> 外文期刊>Plastic and reconstructive surgery >A Randomized Controlled Trial of Skin Care Protocols for Facial Resurfacing: Lessons Learned from the Plastic Surgery Educational Foundation's Skin Products Assessment Research Study.
【24h】

A Randomized Controlled Trial of Skin Care Protocols for Facial Resurfacing: Lessons Learned from the Plastic Surgery Educational Foundation's Skin Products Assessment Research Study.

机译:面部护理皮肤护理方案的随机对照试验:从整形外科教育基金会的皮肤产品评估研究中获得的经验教训。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: : The Skin Products Assessment Research Committee was created by the Plastic Surgery Educational Foundation in 2006. The Skin Products Assessment Research study aims were to (1) develop an infrastructure for Plastic Surgery Educational Foundation-conducted, industry-sponsored research in facial aesthetic surgery and (2) test the research process by comparing outcomes of the Obagi Nu-Derm System versus conventional therapy as treatment adjuncts for facial resurfacing procedures. METHODS: : The Skin Products Assessment Research study was designed as a multicenter, double-blind, randomized, controlled trial. The study was conducted in women with Fitzpatrick type I to IV skin, moderate to severe facial photodamage, and periocular and/or perioral fine wrinkles. Patients underwent chemical peel or laser facial resurfacing and were randomized to the Obagi Nu-Derm System or a standard care regimen. The study endpoints were time to reepithelialization, erythema, and pigmentation changes. RESULTS: : Fifty-six women were enrolled and 82 percent were followed beyond reepithelialization. There were no significant differences in mean time to reepithelialization between Obagi Nu-Derm System and control groups. The Obagi Nu-Derm System group had a significantly higher median erythema score on the day of surgery (after 4 weeks of product use) that did not persist after surgery. Test-retest photographic evaluations demonstrated that both interrater and intrarater reliability were adequate for primary study outcomes. CONCLUSIONS: : The authors demonstrated no significant difference in time to reepithelialization between patients who used the Obagi Nu-Derm System or a standard care regimen as an adjunct to facial resurfacing procedures. The Skin Products Assessment Research team has also provided a discussion of future challenges for Plastic Surgery Educational Foundation-sponsored clinical research for readers of this article.
机译:背景::皮肤产品评估研究委员会是由整形外科教育基金会于2006年成立的。皮肤产品评估研究的目的是(1)为美容外科教育基金会开展的,由行业赞助的面部美容研究基础设施手术和(2)通过比较Obagi Nu-Derm系统与传统疗法作为面部换肤程序的辅助治疗方法的结果来测试研究过程。方法:皮肤产品评估研究设计为多中心,双盲,随机,对照试验。这项研究是针对Fitzpatrick I至IV型皮肤,中度至重度面部光损伤以及眼周和/或口周细皱纹的女性进行的。患者接受化学脱皮或激光面部换肤,并随机分配至Obagi Nu-Derm系统或标准护理方案。研究终点是重新上皮形成,红斑和色素沉着改变的时间。结果:共有56名妇女入组,其中82%的妇女在再次上皮再造后得到随访。 Obagi Nu-Derm系统与对照组之间的再上皮平均时间没有显着差异。 Obagi Nu-Derm系统组在手术当天(使用产品4周后)的中位数红斑得分明显较高,但手术后并未持续。反复测试的摄影评估表明,interrater和raterater的可靠性均足以满足主要研究结果。结论:作者证明在使用Obagi Nu-Derm系统或标准护理方案作为面部换肤程序辅助的患者之间,重新上皮的时间没有显着差异。皮肤产品评估研究团队还为本文的读者讨论了整形外科教育基金会资助的临床研究的未来挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号